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Lead author: Giles J Peek, giles.peek@uhl-tr.nhs.uk Three part clinical question: Patients: Aged 18-65 years with severe but potentially reversible respiratory failure. Intervention: Comparison of conventional management by intermittent positive-pressure ventilation or high frequency oscillatory ventilation or both, against consideration for treatment by extracorporeal membrane oxygenation (ECMO). Outcome: Primary outcome -death or severe disability at six months after randomisation. Secondary outcomes -duration of ventilation, use of high-frequency oscillation or jet ventilation, use of nitric oxide, prone positioning, use of steroids, duration of stay in intensive care and duration of hospital stay. Health status at six months after randomisation was assessed from activities of daily living, quality of life, respiratory symptoms, cognitive psychological state and lung function.
Search terms: ARDS, ALI, therapy, respiratory failure, ECMO.
The study: Non-blinded, randomised controlled trial with intention-to-treat analysis.
The study patients: Eligible patients were aged 18-65 years with severe but potentially reversible respiratory failure, and a Murray score of 3 or higher or uncompensated hypercapnoea with a pH of less than 7.20 despite optimum conventional treatment.
Control group: (n=90; 87 analysed): Patients randomly allocated to receive conventional management were given the best critical care practice available in their treatment centre. As a pragmatic trial, a specific management protocol was not mandated, but treatment centres were advised to follow a lowvolume/low-pressure ventilation strategy.
Experimental group: (n=90; 90 analysed): Patients randomly allocated to consideration for treatment by ECMO were transferred to Glenfield Hospital. If patients were haemodynamically stable, a standard acute respiratory distress syndrome treatment protocol was used: • Pressure-restricted mechanical ventilation at 30 cm H 2 O • Positive end expiratory pressure titrated to optimum SaO 2
Extracorporeal membrane oxygenation for severe respiratory failure
Management of severe respiratory failure in a specialist centre which is capable of delivering a complex 'bundle' of care including a strict acute respiratory distress syndrome (ARDS) protocol, extracorporeal membrane oxygenation (ECMO), molecular adsorbent recycling system (MARS) and steroids, may improve outcomes when compared with conventional care. It is difficult to comment on the value of ECMO alone based on this study.
Level of evidence: 1 + (RCT with a low risk of bias)
Appraised by: C Hawthorne, P McConnell, C Cairns If patients did not respond to this protocol within 12 hours or were haemodynamically unstable, they were cannulated and received ECMO. Lung rest settings were: peak inspiratory pressure 20-25 cm H 2 O, positive end-expiratory pressure 10-15 cm H 2 O, rate 10, and FiO 2 0·3. ECMO was continued until lung recovery, or until apparently irreversible multiorgan failure.
Results
• Only 68 of the 90 patients in the intervention group received ECMO. Three died prior to transfer. Two died in transit. Seventeen responded to the 12 hour ARDS protocol (14 of these survived). • 43 of the 68 ECMO patients survived.
• Removal of the survivor with severe disability from the analysis would render the benefit non-significant. 
